Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Escherichia coli | 7 | 2022 | 980 | 1.150 |
Why?
|
| PPAR gamma | 7 | 2020 | 91 | 1.080 |
Why?
|
| beta-Lactamases | 3 | 2009 | 195 | 0.790 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2022 | 362 | 0.710 |
Why?
|
| Amino Acid Substitution | 2 | 2014 | 389 | 0.700 |
Why?
|
| Escherichia coli Proteins | 1 | 2022 | 303 | 0.680 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 2533 | 0.590 |
Why?
|
| Biphenyl Compounds | 2 | 2015 | 56 | 0.510 |
Why?
|
| Homeostasis | 2 | 2019 | 681 | 0.510 |
Why?
|
| Osteogenesis | 2 | 2015 | 153 | 0.480 |
Why?
|
| Indoles | 1 | 2015 | 181 | 0.460 |
Why?
|
| Osteoblasts | 1 | 2015 | 149 | 0.460 |
Why?
|
| Hypoglycemic Agents | 2 | 2015 | 423 | 0.460 |
Why?
|
| Bacterial Proteins | 8 | 2014 | 876 | 0.450 |
Why?
|
| Biological Evolution | 1 | 2014 | 221 | 0.430 |
Why?
|
| Bone and Bones | 1 | 2015 | 262 | 0.430 |
Why?
|
| Mutant Proteins | 2 | 2009 | 112 | 0.400 |
Why?
|
| Mutation | 6 | 2022 | 5774 | 0.390 |
Why?
|
| Suppression, Genetic | 2 | 2008 | 43 | 0.390 |
Why?
|
| Transcription, Genetic | 2 | 2016 | 1695 | 0.380 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 2397 | 0.360 |
Why?
|
| Catalytic Domain | 1 | 2009 | 160 | 0.320 |
Why?
|
| Hypertension, Pulmonary | 2 | 2023 | 431 | 0.310 |
Why?
|
| Proline | 1 | 2008 | 73 | 0.300 |
Why?
|
| Endothelial Cells | 3 | 2023 | 528 | 0.300 |
Why?
|
| Arginine | 1 | 2009 | 298 | 0.290 |
Why?
|
| Cell Differentiation | 1 | 2015 | 1916 | 0.290 |
Why?
|
| Serratia marcescens | 1 | 2007 | 10 | 0.290 |
Why?
|
| Leucine | 1 | 2008 | 309 | 0.280 |
Why?
|
| Imidazoles | 2 | 2020 | 199 | 0.280 |
Why?
|
| Piperazines | 2 | 2020 | 231 | 0.270 |
Why?
|
| Pulmonary Artery | 4 | 2023 | 439 | 0.260 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2020 | 715 | 0.230 |
Why?
|
| Serine Endopeptidases | 3 | 2014 | 175 | 0.220 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2022 | 798 | 0.220 |
Why?
|
| Mitochondrial Dynamics | 1 | 2024 | 46 | 0.220 |
Why?
|
| RNA, Small Untranslated | 1 | 2022 | 21 | 0.200 |
Why?
|
| Colistin | 1 | 2022 | 30 | 0.200 |
Why?
|
| Crystallography, X-Ray | 7 | 2015 | 357 | 0.200 |
Why?
|
| Ciprofloxacin | 1 | 2022 | 66 | 0.200 |
Why?
|
| Vascular Diseases | 1 | 2023 | 163 | 0.190 |
Why?
|
| DNA Repair | 2 | 2019 | 582 | 0.190 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2020 | 21 | 0.180 |
Why?
|
| Selection, Genetic | 2 | 2014 | 155 | 0.180 |
Why?
|
| Protein Conformation | 5 | 2015 | 836 | 0.180 |
Why?
|
| Models, Molecular | 7 | 2015 | 1070 | 0.170 |
Why?
|
| Periplasmic Proteins | 2 | 2010 | 6 | 0.170 |
Why?
|
| Neovascularization, Physiologic | 1 | 2020 | 211 | 0.170 |
Why?
|
| Proteins | 3 | 2014 | 1039 | 0.160 |
Why?
|
| Retinoid X Receptor alpha | 2 | 2017 | 17 | 0.160 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2018 | 33 | 0.160 |
Why?
|
| Sequence Analysis, Protein | 3 | 2013 | 49 | 0.160 |
Why?
|
| HEK293 Cells | 3 | 2019 | 740 | 0.160 |
Why?
|
| Viral Vaccines | 1 | 2021 | 325 | 0.160 |
Why?
|
| DNA | 2 | 2017 | 1592 | 0.160 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 2018 | 18 | 0.150 |
Why?
|
| Regeneration | 1 | 2020 | 202 | 0.150 |
Why?
|
| Molecular Sequence Data | 8 | 2012 | 3871 | 0.150 |
Why?
|
| Molecular Docking Simulation | 1 | 2018 | 113 | 0.150 |
Why?
|
| 3T3-L1 Cells | 2 | 2015 | 56 | 0.150 |
Why?
|
| Crystallography | 2 | 2015 | 40 | 0.150 |
Why?
|
| Transcription Factors | 2 | 2019 | 2577 | 0.140 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2015 | 288 | 0.140 |
Why?
|
| Deuterium Exchange Measurement | 2 | 2017 | 6 | 0.140 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 597 | 0.140 |
Why?
|
| Kinetics | 2 | 2009 | 1313 | 0.140 |
Why?
|
| Plasmids | 2 | 2008 | 511 | 0.140 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 207 | 0.130 |
Why?
|
| Binding Sites | 5 | 2018 | 1292 | 0.130 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 353 | 0.130 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2017 | 201 | 0.130 |
Why?
|
| Gene Editing | 1 | 2018 | 187 | 0.130 |
Why?
|
| Phosphorylation | 3 | 2015 | 1611 | 0.130 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 251 | 0.130 |
Why?
|
| Models, Genetic | 2 | 2018 | 767 | 0.120 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2010 | 657 | 0.120 |
Why?
|
| Adipogenesis | 1 | 2015 | 76 | 0.120 |
Why?
|
| Protein Binding | 5 | 2019 | 1743 | 0.120 |
Why?
|
| Ligands | 4 | 2018 | 533 | 0.120 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 326 | 0.110 |
Why?
|
| Protein Interaction Mapping | 1 | 2014 | 85 | 0.110 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 353 | 0.110 |
Why?
|
| Amino Acid Sequence | 7 | 2012 | 2698 | 0.110 |
Why?
|
| Feedback | 1 | 2014 | 163 | 0.110 |
Why?
|
| Oxidative Stress | 3 | 2024 | 796 | 0.110 |
Why?
|
| Evolution, Molecular | 3 | 2013 | 672 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2011 | 317 | 0.100 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 2 | 2023 | 16 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 1338 | 0.100 |
Why?
|
| Protein Structure, Quaternary | 2 | 2009 | 98 | 0.100 |
Why?
|
| Sequence Alignment | 5 | 2012 | 623 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2011 | 11 | 0.100 |
Why?
|
| Rec A Recombinases | 1 | 2011 | 26 | 0.100 |
Why?
|
| DNA, Bacterial | 2 | 2018 | 481 | 0.100 |
Why?
|
| Ovarian Neoplasms | 1 | 2015 | 407 | 0.100 |
Why?
|
| Protein Structure, Secondary | 2 | 2009 | 239 | 0.100 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2010 | 12 | 0.090 |
Why?
|
| Mice | 6 | 2023 | 17486 | 0.090 |
Why?
|
| Signal Transduction | 3 | 2020 | 4500 | 0.090 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 227 | 0.090 |
Why?
|
| Thermotoga maritima | 1 | 2010 | 1 | 0.090 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 940 | 0.090 |
Why?
|
| Prokaryotic Cells | 1 | 2009 | 6 | 0.090 |
Why?
|
| Exodeoxyribonucleases | 1 | 2010 | 49 | 0.090 |
Why?
|
| Endodeoxyribonucleases | 1 | 2010 | 47 | 0.090 |
Why?
|
| Animals | 8 | 2023 | 33728 | 0.090 |
Why?
|
| Apoptosis | 2 | 2015 | 1782 | 0.080 |
Why?
|
| Bacteroides | 1 | 2010 | 34 | 0.080 |
Why?
|
| DNA, Single-Stranded | 1 | 2010 | 66 | 0.080 |
Why?
|
| Caulobacter crescentus | 1 | 2009 | 3 | 0.080 |
Why?
|
| Computational Biology | 1 | 2014 | 800 | 0.080 |
Why?
|
| Phosphotransferases | 1 | 2009 | 41 | 0.080 |
Why?
|
| Histidine | 1 | 2009 | 72 | 0.080 |
Why?
|
| Enzyme Stability | 1 | 2008 | 58 | 0.080 |
Why?
|
| Ampicillin | 1 | 2008 | 58 | 0.080 |
Why?
|
| Microbial Viability | 1 | 2008 | 41 | 0.080 |
Why?
|
| Humans | 16 | 2024 | 123180 | 0.080 |
Why?
|
| Hydrolysis | 1 | 2008 | 155 | 0.080 |
Why?
|
| DNA Damage | 2 | 2023 | 507 | 0.080 |
Why?
|
| Thermodynamics | 1 | 2008 | 141 | 0.080 |
Why?
|
| Adenosine Triphosphatases | 1 | 2008 | 208 | 0.070 |
Why?
|
| Neoplasms | 1 | 2022 | 2766 | 0.070 |
Why?
|
| Software | 1 | 2012 | 677 | 0.070 |
Why?
|
| Protein Sorting Signals | 1 | 2007 | 38 | 0.070 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2007 | 42 | 0.070 |
Why?
|
| Phylogeny | 1 | 2009 | 685 | 0.070 |
Why?
|
| Carbapenems | 1 | 2007 | 36 | 0.070 |
Why?
|
| Genes, Bacterial | 1 | 2007 | 208 | 0.070 |
Why?
|
| Proteome | 2 | 2021 | 233 | 0.070 |
Why?
|
| DNA Primers | 1 | 2007 | 661 | 0.070 |
Why?
|
| Bacteria | 1 | 2009 | 483 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2010 | 811 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 3 | 2010 | 752 | 0.060 |
Why?
|
| Familial Primary Pulmonary Hypertension | 1 | 2023 | 19 | 0.060 |
Why?
|
| Vascular Remodeling | 1 | 2023 | 41 | 0.050 |
Why?
|
| Base Sequence | 1 | 2007 | 3093 | 0.050 |
Why?
|
| RNA Polymerase III | 1 | 2022 | 39 | 0.050 |
Why?
|
| Molecular Sequence Annotation | 2 | 2013 | 144 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 369 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2022 | 409 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 262 | 0.050 |
Why?
|
| Structural Homology, Protein | 2 | 2010 | 26 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2008 | 2048 | 0.040 |
Why?
|
| Farnesol | 1 | 1999 | 3 | 0.040 |
Why?
|
| Salicylates | 1 | 1999 | 53 | 0.040 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 1999 | 12 | 0.040 |
Why?
|
| Conserved Sequence | 2 | 2010 | 293 | 0.040 |
Why?
|
| Chromatin | 1 | 2022 | 552 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2024 | 765 | 0.040 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2019 | 93 | 0.040 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2018 | 65 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2019 | 172 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 126 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2018 | 104 | 0.040 |
Why?
|
| Carbon-13 Magnetic Resonance Spectroscopy | 1 | 2017 | 2 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2015 | 1062 | 0.040 |
Why?
|
| Genomic Instability | 1 | 2019 | 229 | 0.040 |
Why?
|
| Genome, Bacterial | 1 | 2018 | 184 | 0.040 |
Why?
|
| Inflammation | 1 | 2024 | 1402 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2023 | 2307 | 0.030 |
Why?
|
| Algorithms | 2 | 2013 | 1597 | 0.030 |
Why?
|
| Lung | 1 | 2023 | 1469 | 0.030 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2015 | 84 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 3049 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 2851 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2015 | 893 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2014 | 284 | 0.030 |
Why?
|
| Models, Biological | 1 | 2019 | 1442 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 665 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2013 | 91 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 803 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2020 | 3716 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 1999 | 802 | 0.030 |
Why?
|
| Phosphoserine | 1 | 2011 | 41 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2011 | 78 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2012 | 153 | 0.020 |
Why?
|
| Homologous Recombination | 1 | 2011 | 92 | 0.020 |
Why?
|
| COS Cells | 1 | 2011 | 273 | 0.020 |
Why?
|
| Body Fluids | 1 | 2011 | 48 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2011 | 137 | 0.020 |
Why?
|
| Thiazolidinediones | 1 | 2011 | 79 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2011 | 79 | 0.020 |
Why?
|
| Static Electricity | 1 | 2010 | 40 | 0.020 |
Why?
|
| Adipocytes | 1 | 2011 | 158 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 1999 | 1677 | 0.020 |
Why?
|
| Cell Line | 1 | 2015 | 2776 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2010 | 86 | 0.020 |
Why?
|
| Eukaryotic Cells | 1 | 2009 | 31 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2011 | 296 | 0.020 |
Why?
|
| Surface Properties | 1 | 2009 | 76 | 0.020 |
Why?
|
| Shewanella | 1 | 2008 | 8 | 0.020 |
Why?
|
| Peptides | 1 | 2012 | 796 | 0.020 |
Why?
|
| Weight Gain | 1 | 2011 | 401 | 0.020 |
Why?
|
| Dimerization | 1 | 2008 | 144 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 670 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2008 | 286 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 1683 | 0.020 |
Why?
|
| Female | 3 | 2020 | 65428 | 0.010 |
Why?
|
| Male | 3 | 2020 | 60022 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 4346 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 4267 | 0.010 |
Why?
|
| Obesity | 1 | 2011 | 2229 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 1999 | 72 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 1999 | 254 | 0.010 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1999 | 155 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 1999 | 426 | 0.010 |
Why?
|
| Mice, SCID | 1 | 1999 | 571 | 0.010 |
Why?
|
| Cell Division | 1 | 1999 | 779 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 1999 | 6372 | 0.000 |
Why?
|
| Aged | 1 | 1999 | 19072 | 0.000 |
Why?
|